Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, Gwangju, Korea.
Korean J Anesthesiol. 2010 Nov;59(5):305-9. doi: 10.4097/kjae.2010.59.5.305. Epub 2010 Nov 25.
Pain upon the injection of propofol is a common adverse effect. This study was conducted to evaluate the analgesic effect of remifentanil and cold propofol during propofol injection for the induction of anesthesia and to determine if a combination of cold propofol and remifentanil produced additional analgesic efficacy.
A total of 160 patients aged 20-65 years old were randomly allocated into one of four groups (n = 40, in each). Control and remifentanil group patients received 2 mg/kg propofol that had been stored at room temperature (20-23℃), while the cold and combination group received cold (4℃) propofol. The patients received remifentanil 0.5 µg/kg IV in the remifentanil and combination groups or saline in the control and cold groups. Ninety seconds after administration the patients were administered propofol over a 30 second period. The pain intensity and incidence were then evaluated using a 4-point verbal rating scale.
The incidence of pain was significantly reduced in groups that received remifentanil in the cold and combination groups when compared with the control group (27.5%, 30%, and 2.5% vs. 70%, respectively). Moreover, the severity of pain was significantly lower in groups that received remifentanil in the cold and combination groups when compared with the control group. The incidence and severity of pain from the propofol injection in the combination group was significantly lower than that in the remifentanil and cold groups.
The combination of cold propofol and pretreatment with remifentanil more effectively reduced the incidence of pain upon the injection of propofol than either treatment alone.
丙泊酚注射痛是一种常见的不良反应。本研究旨在评估瑞芬太尼和冷丙泊酚在丙泊酚注射诱导麻醉时的镇痛效果,并确定冷丙泊酚和瑞芬太尼联合应用是否具有额外的镇痛效果。
将 160 例 20-65 岁患者随机分为四组(每组 40 例)。对照组和瑞芬太尼组患者给予室温(20-23℃)储存的 2mg/kg 丙泊酚,而冷组和联合组给予冷(4℃)丙泊酚。瑞芬太尼和联合组患者给予瑞芬太尼 0.5μg/kg 静脉注射,对照组和冷组患者给予生理盐水。给药 90 秒后,患者在 30 秒内给予丙泊酚。然后使用 4 分制语言评分量表评估疼痛强度和发生率。
与对照组相比,接受冷丙泊酚和联合用药的瑞芬太尼组疼痛发生率显著降低(分别为 27.5%、30%和 2.5%与 70%)。此外,与对照组相比,接受冷丙泊酚和联合用药的瑞芬太尼组疼痛程度明显较轻。与瑞芬太尼和冷丙泊酚组相比,联合用药组丙泊酚注射引起的疼痛发生率和严重程度明显较低。
与单独使用冷丙泊酚或瑞芬太尼预处理相比,冷丙泊酚和瑞芬太尼联合应用更有效地降低了丙泊酚注射引起的疼痛发生率。